AVT03, approved in Japan as DENOSUMAB BS 120 mg/1.4 mL in a vial for subcutaneous injection, is a biosimilar to Ranmark® (denosumab), which is marketed in some other countries globally as Xgeva® ...

TNF-driven inflammatory arthritis, commonly accompanied by vitamin D deficiency. Here, we investigate the interaction between ...

Spyre's innovative ulcerative colitis antibody therapies, phase 2 trial progress, and strong cash position to drive drug ...

The firm, which so far has focused on cancer, expects to file an IND application for a treatment for tyrosinemia type I and alkaptonuria next year.

Persistent back pain, often dismissed, could signal a serious underlying issue like lung cancer, warns Dr. Kamran Ali. Unlike ...

Founded by Dr. Haraprasad, Global Health is a trusted centre for non-surgical treatment of chronic spine, joint, and ...

The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis.

Learning about early symptoms may help you in the long run. Here are the early symptoms to know, according to medical ...

Any Lyme test available for sale at a drugstore or website is unapproved, says Andrea Love, a microbiologist and director of ...

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help ...